ストックスクリーナーアプリを入手
23.53
0.72%
-0.17
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Canada
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium gains on accelerated share buybacks (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Pharmaceutical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Collegium Pharmaceutical (COLL) Slips 0.85% While Holding Above Key Support at $25.62Breakout Trade - vinanet.vn
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 6.5%Here's What Happened - MarketBeat
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - Yahoo Finance
Collegium Pharmaceutical, Inc. Revenue Breakdown – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Stock Revenue Growth Masks Deepening Margin Squeeze - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 - Moomoo
Collegium Pharmaceutical (COLL) Stock May Trade At A Discount Even After A 60% Return - simplywall.st
Piper Sandler Reiterates Neutral Rating for Collegium Pharmaceutical (NASDAQ:COLL) - MarketBeat
Is Now The Time To Put Collegium Pharmaceutical (NASDAQ:COLL) On Your Watchlist? - Moomoo
Collegium Pharmaceutical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:COLL) 2026-08-07 - Seeking Alpha
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unveiling an 82.76% Potential Upside - DirectorsTalk Interviews
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 1-Year Low Following Analyst Downgrade - MarketBeat
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Collegium Pharmaceutical stock hits 52-week low at 30.11 USD - Investing.com
Collegium Pharmaceutical, Inc. Stock 12‑Month Price Target Cut to $51.2, Implies 43% Upside - TradingView
Needham & Company LLC Cuts Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00 - MarketBeat
Collegium Pharmaceutical Releases Q2 2026 Financial Results - AlphaStreet
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap DownShould You Sell? - MarketBeat
Collegium Pharmaceutical Down Over 13%, On Track for Largest Percent Decrease Since May 2024 -- Data Talk - Moomoo
Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Collegium Pharmaceutical Q2 Earnings Call Highlights - MarketBeat
Collegium Pharmaceutical falls 13% on weak revenue guidance By Investing.com - Investing.com South Africa
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops - Yahoo Finance
Collegium Pharmaceutical: Q2 Earnings Snapshot - marketscreener.com
Collegium Pharmaceutical Reports Q2 2026 Results, Completes AZSTARYS Acquisition and Raises Full-Year Guidance - Quiver Quantitative
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress - Yahoo Finance
Collegium Pharmaceutical, Inc. $COLL Shares Acquired by Sei Investments Co. - MarketBeat
1.66%
0.33%
大文字化:
|
ボリューム (24 時間):